{"status": "ok", "totalResults": 8, "articles": [{"source": {"id": null, "name": "Neurosciencenews.com"}, "author": "Neuroscience News", "title": "Single Protein Rewires the Brain to Adapt to Motherhood - Neuroscience News", "description": "The presence of the MECP2 protein in parvalbumin (PV) neurons is crucial for newly-mothering mice to rapidly learn and respond to their pups\u2019 distress cries, hinting at how the brain rewires during pivotal adult learning phases.", "url": "https://neurosciencenews.com/motherhood-brain-genetics-24912/", "urlToImage": "https://neurosciencenews.com/files/2023/10/brain-motherhood-neuroscience.jpg", "publishedAt": "2023-10-04T18:59:56Z", "content": "Summary: The presence of the MECP2 protein in parvalbumin (PV) neurons is crucial for newly-mothering mice to rapidly learn and respond to their pups distress cries, hinting at how the brain rewires \u2026 [+6187 chars]"}, {"source": {"id": null, "name": "[Removed]"}, "author": null, "title": "[Removed]", "description": "[Removed]", "url": "https://removed.com", "urlToImage": null, "publishedAt": "1970-01-01T00:00:00Z", "content": "[Removed]"}, {"source": {"id": null, "name": "Nature.com"}, "author": null, "title": "Sialoglycan binding triggers spike opening in a human coronavirus - Nature.com", "description": "Binding of a sialoglycan-based primary receptor by the spike protein of the common cold human coronavirus HKU1 triggers conformational changes to a state that would allow binding to a second receptor required for cell entry.", "url": "https://www.nature.com/articles/s41586-023-06599-z", "urlToImage": "https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41586-023-06599-z/MediaObjects/41586_2023_6599_Fig1_HTML.png", "publishedAt": "2023-10-04T15:20:14Z", "content": null}, {"source": {"id": null, "name": "Multiple Sclerosis News Today"}, "author": "Marisa Wexler, MS", "title": "MS patients in UK less likely to be on treatment, new study shows... - Multiple Sclerosis News Today", "description": "Compared with MS patients in other countries in Europe, those in the U.K. are less likely to be on disease-modifying treatment, a study shows.", "url": "https://multiplesclerosisnewstoday.com/news-posts/2023/10/04/ms-patients-uk-less-likely-other-countries-use-treatment-study/", "urlToImage": "https://multiplesclerosisnewstoday.com/wp-content/uploads/2023/03/DifferentMeds.png", "publishedAt": "2023-10-04T14:02:46Z", "content": "People with multiple sclerosis (MS) in the United Kingdom are less likely to be on disease-modifying treatments (DMTs) compared with MS patients in other countries in Europe, a new study reports.\r\n\u201cW\u2026 [+6864 chars]"}, {"source": {"id": null, "name": "[Removed]"}, "author": null, "title": "[Removed]", "description": "[Removed]", "url": "https://removed.com", "urlToImage": null, "publishedAt": "1970-01-01T00:00:00Z", "content": "[Removed]"}, {"source": {"id": null, "name": "[Removed]"}, "author": null, "title": "[Removed]", "description": "[Removed]", "url": "https://removed.com", "urlToImage": null, "publishedAt": "1970-01-01T00:00:00Z", "content": "[Removed]"}, {"source": {"id": null, "name": "[Removed]"}, "author": null, "title": "[Removed]", "description": "[Removed]", "url": "https://removed.com", "urlToImage": null, "publishedAt": "1970-01-01T00:00:00Z", "content": "[Removed]"}, {"source": {"id": null, "name": "Cam.ac.uk"}, "author": null, "title": "Type 2 diabetes diagnosis at age 30 can reduce life expectancy by up to 14 years - University of Cambridge news", "description": "An individual diagnosed with type 2 diabetes at age 30 years could see their life expectancy fall by as much as 14 years, an international team of researchers", "url": "https://www.cam.ac.uk/research/news/type-2-diabetes-diagnosis-at-age-30-can-reduce-life-expectancy-by-up-to-14-years", "urlToImage": "https://www.cam.ac.uk/sites/www.cam.ac.uk/files/news/research/news/gettyimages-1205767883-web.jpg", "publishedAt": "2023-10-03T09:47:07Z", "content": "Even people who do not develop the condition until later in life with a diagnosis at age 50 years could see their life expectancy fall by up to six years, an analysis of data from 19 high-income coun\u2026 [+4115 chars]"}]}